diabetesincontrol.com
New Information in Diabetes Research: What Clinicians Need to Know
Discover groundbreaking diabetes research breakthroughs offering new hope for treatment and management of this chronic condition.
How is Empagliflozin Used In Diabetes Care?
Discover how empagliflozin, an SGLT2 inhibitor, enhances diabetes care by managing blood sugar, promoting weight loss, and reducing cardiovascular risks.
New Research: 1 in 4 US Adults with Diabetes Tried GLP-1 Drugs
New research reveals 1 in 4 U.S. adults with diabetes have tried GLP-1 drugs, highlighting a shift in diabetes management with these innovative treatments.
Why Diabetes Tech Is On The Rise?
Discover how diabetes tech is transforming care with innovative tools for better management and improved patient outcomes globally.
Why Some Patients Think They Have Diabetes In Control
Explore why some patients mistakenly believe they have diabetes in control, highlighting the importance of continuous monitoring and patient education.
Understanding Canagliflozin and Diabetes
Discover Canagliflozin's unique approach in managing type 2 diabetes by reducing blood sugar levels and enhancing overall treatment outcomes.
What is Sitagliptin?
Discover the role of Sitagliptin, a DPP-4 inhibitor, in managing type 2 diabetes by enhancing the body's natural insulin response.